Gemtuzumab ozogamicin
About
Therapy type: Immunotherapy
Therapy strategy: CD33 inhibition
Mappings
NCI Thesaurus: Gemtuzumab Ozogamicin (ncit:C1806)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | CD33 + | Acute Lymphoid Leukemia | Gemtuzumab ozogamicin | |
| Sensitivity (+) | CD33 + | Acute Lymphoid Leukemia | Gemtuzumab ozogamicin | |
| Sensitivity (+) | CD33 + | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Gemtuzumab ozogamicin | |
| Sensitivity (+) | CD33 + | Acute Lymphoid Leukemia | Cytarabine, Daunorubicin, Gemtuzumab ozogamicin |